Association of mortality with drug-coated devices in femoropopliteal artery based on the nationwide dataopen access
- Authors
- Choi, Hyunsook; Lee, Haine; Lee, Sang-Soo; Ahn, Jeonghoon; Joh, Jin Hyun; Lee, Moo-Yeol
- Issue Date
- Jul-2021
- Publisher
- 대한외과학회
- Keywords
- Angioplasty; Mortality; Paclitaxel; Peripheral arterial occlusive disease; Stents
- Citation
- Annals of Surgical Treatment and Research, v.101, no.1, pp 20 - 27
- Pages
- 8
- Journal Title
- Annals of Surgical Treatment and Research
- Volume
- 101
- Number
- 1
- Start Page
- 20
- End Page
- 27
- URI
- https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/50258
- DOI
- 10.4174/astr.2021.101.1.20
- ISSN
- 2288-6575
2288-6796
- Abstract
- Purpose: Drug-coated devices have been widely accepted as one of the most promising therapies for femoropopliteal artery revascularization. A recent meta-analysis showed increased mortality in patients treated with drug-coated devices. We sought to examine the association between mortality and drug-coated devices after the treatment of the femoropopliteal artery based on the Korea national administrative claims data.
Methods: In the National Health Insurance Service database from August 2015 to December 2017, we identified patients with femoropopliteal artery revascularization using percutaneous transluminal angioplasty (PTA), bare metal stents (BMS), drug-coated balloon (DCB), or drug-eluting stents (DES). Kaplan-Meier methods were used to estimate the survival among devices, and log-rank tests were used to evaluate differences between groups. Adjusted hazard ratios (aHRs) were computed using the inverse probability of treatment weightings (IPTW).
Results: There were 1,724 patients (mean age, 70.9 ± 10.7 years; male, 1,350 [78.3%]) included in the analysis. The median follow-up period was 552 days (interquartile range, 404–688 days). There was a difference in IPTW-adjusted mortality risk among device types (26.3% in PTA, 22.1% in BMS, 17.7% in DCB, and 17.8% in DES; P = 0.004). IPTW-adjusted Cox proportional hazard analysis showed that drug-coated devices were associated with decreased all-cause mortality risk (aHR, 0.70; 95% confidence interval, 0.58–0.86).
Conclusion: Our real-world analysis showed that there was no evidence of increased all-cause mortality after femoropopliteal artery revascularization with drug-coated devices compared with non-drug-coated devices.
- Files in This Item
-
- Appears in
Collections - College of Medicine > College of Medicine > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/50258)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.